Metis Biotech‘s experimental oral therapy MTS-004 was safe and eased symptoms of pseudobulbar affect (PBA), a neurological condition marked by bouts of sudden, involuntary, and inappropriate laughter or crying, in […]
The post MTS-004 eases pseudobulbar affect in people with MS, other disorders appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com